Quinn Robert R, Mohamed Farah, Pauly Robert, Schwartz Tracy, Scott-Douglas Nairne, Morrin Louise, Kozinski Anita, Manns Braden J, Klarenbach Scott, Clarke Alix, Fox Danielle E, Oliver Matthew J
Cumming School of Medicine, University of Calgary, AB, Canada.
Department of Community Health Sciences, University of Calgary, AB, Canada.
Can J Kidney Health Dis. 2021 Mar 31;8:20543581211003764. doi: 10.1177/20543581211003764. eCollection 2021.
Most of the patients with end-stage kidney failure are treated with dialysis. Jurisdictions around the world are actively promoting peritoneal dialysis (PD) because it is equivalent to hemodialysis in terms of clinical outcomes, but is less costly. Unfortunately, PD penetration remains low.
The Starting dialysis on Time, At Home, on the Right Therapy (START) Project had 2 overarching goals: (1) to provide information that would help programs increase the safe and effective use of PD, and (2) to reduce inappropriate, early initiation of dialysis in patients with kidney failure. In this article, we focus on the first objective and describe the rationale for START and the methods employed.
The START Project was a comprehensive, province-wide quality improvement intervention.
The START project was implemented in both Alberta Kidney Care (AKC)-South and AKC-North, including all 7 renal programs in the province.
The project included all patients who commenced maintenance dialysis between October 1, 2015, and March 31, 2018, in Alberta, Canada who met our inclusion criteria.
We reported baseline characteristics of incident dialysis patients overall, and by site. Our key performance indicator was the proportion of patients who received PD for any period of time within 180 days of the first dialysis treatment. Reports also included detailed metrics pertaining to the 6 steps in the process of modality selection and we had the capacity to provide more granular data on an as-needed basis. To understand loss of PD patients, we reported the numbers of incident patients who recovered kidney function, experienced technique failure, received a transplant, were lost to follow-up, transferred to another program, or died.
START provided dialysis programs with a conceptual framework for understanding the drivers of PD utilization. High-quality, detailed data were collected using a tool that was custom-built for this purpose, and were mapped to steps in the process of care that drove the outcomes of interest. This allowed sites to identify gaps in care, develop action plans, and implement local interventions to address them. The process was supported by an Innovation Learning Collaborative consisting of 3 learning sessions that brought frontline staff together from across the province to share strategies and learnings. Ongoing data collection allowed teams to determine whether their interventions were effective at each subsequent learning session, and to revisit their interventions if required (the "Plan-Do-Study-Act Cycle").
Future work will report on the impact of the START project on incident PD utilization at a provincial and regional level.
The time required to design and implement interventions in practice, as well as the need for multiple PDSA (Plan-Do-Study-Act) cycles to see results, meant that the true potential may not be realized during a relatively short intervention period. Change required buy-in and support from local and provincial leadership and frontline staff. In the absence of accountability for local performance, we relied on the goodwill of participating programs to use the information and resources provided to effect change. Finally, the burden of documentation and data collection for frontline staff was high at baseline. We anticipated that adding supplemental data collection would be difficult.
The START project was a comprehensive, province-wide initiative to maximize the safe and effective use of PD in Alberta, Canada. It standardized the management of incident dialysis patients, leveraged high-quality data to facilitate the reporting of metrics mapped to steps in the process of care that drove incident PD utilization, and helped programs to identify gaps in care and target them for improvement. Future work will report on the impact of the program on incident utilization at the provincial and regional level.
大多数终末期肾衰竭患者接受透析治疗。世界各地的司法管辖区都在积极推广腹膜透析(PD),因为就临床结果而言,它与血液透析相当,但成本更低。不幸的是,腹膜透析的普及率仍然很低。
及时、在家、采用正确疗法开始透析(START)项目有两个总体目标:(1)提供有助于项目增加腹膜透析安全有效使用的信息,(2)减少肾衰竭患者不适当的早期透析开始。在本文中,我们关注第一个目标,并描述START项目的基本原理和所采用的方法。
START项目是一项全面的、全省范围的质量改进干预措施。
START项目在艾伯塔省肾脏护理中心(AKC)南部和AKC北部实施,包括该省所有7个肾脏项目。
该项目包括2015年10月1日至2018年3月31日期间在加拿大艾伯塔省开始维持性透析且符合我们纳入标准的所有患者。
我们报告了新透析患者的总体基线特征以及按地点划分的特征。我们的关键绩效指标是首次透析治疗后180天内任何时间段接受腹膜透析的患者比例。报告还包括与透析方式选择过程中的6个步骤相关的详细指标,并且我们有能力根据需要提供更详细的数据。为了解腹膜透析患者流失情况,我们报告了肾功能恢复、出现技术失败、接受移植、失访、转至另一个项目或死亡的新发病例患者数量。
START为透析项目提供了一个理解腹膜透析使用驱动因素的概念框架。使用为此目的定制构建的工具收集高质量、详细的数据,并将其映射到推动感兴趣结果的护理过程步骤中。这使各地点能够识别护理差距,制定行动计划,并实施当地干预措施来解决这些差距。该过程得到了一个创新学习协作组织的支持,该组织包括3次学习会议,将全省的一线工作人员聚集在一起分享策略和经验教训。持续的数据收集使各团队能够在每次后续学习会议上确定其干预措施是否有效,并在需要时重新审视其干预措施(“计划 - 执行 - 研究 - 行动循环”)。
未来的工作将报告START项目对省级和地区级新发病例腹膜透析使用的影响。
在实践中设计和实施干预措施所需的时间,以及需要多个计划 - 执行 - 研究 - 行动(PDSA)循环才能看到结果,这意味着在相对较短的干预期内可能无法实现真正的潜力。变革需要地方和省级领导以及一线工作人员的认可和支持。在缺乏对地方绩效问责的情况下,我们依赖参与项目的善意来使用提供的信息和资源以实现变革。最后,基线时一线工作人员的文件记录和数据收集负担很重。我们预计增加补充数据收集会很困难。
START项目是加拿大艾伯塔省一项全面的、全省范围的倡议,旨在最大限度地安全有效地使用腹膜透析。它规范了新发病例透析患者的管理,利用高质量数据促进了与推动新发病例腹膜透析使用的护理过程步骤相关指标的报告,并帮助项目识别护理差距并针对这些差距进行改进。未来的工作将报告该项目对省级和地区级新发病例使用情况的影响。